Literature DB >> 8750177

Liver-directed gene therapy: molecular tools and current preclinical and clinical studies.

M Alt1, W H Caselmann.   

Abstract

Mesh：

Year:  1995        PMID： 8750177     DOI： 10.1016/0168-8278(95)80044-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  3 in total

1.  Fas and TNFR1, but not cytolytic granule-dependent mechanisms, mediate clearance of murine liver adenoviral infection.

Authors:  Marwan S Abougergi; Sarah J Gidner; David K Spady; Bonnie C Miller; Dwain L Thiele
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

Review 2.  On the design of broad based screening assays to identify potential pharmacological chaperones of protein misfolding diseases.

Authors:  Subhashchandra Naik; Na Zhang; Phillip Gao; Mark T Fisher
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

3.  Killing of p53-deficient hepatoma cells by parvovirus H-1 and chemotherapeutics requires promyelocytic leukemia protein.

Authors:  Maike Sieben; Kerstin Herzer; Maja Zeidler; Vera Heinrichs; Barbara Leuchs; Martin Schuler; Jan-J Cornelis; Peter-R Galle; Jean Rommelaere; Markus Moehler
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.